PNPLA3 and metabolic dysfunction-associated steatotic liver disease: The present study investigated whether bioactive compounds have a protective effect on NAFLD and whether this protective effect comes from regulating energy homeostasis and the AMPK/autophagy signaling pathways linked to PNPLA3.